Skip to content
ppharmaranks
Menu

Best treatments for ventricular premature complexes

2 products may treat ventricular premature complexes, spanning FDA drug classes such as antiarrhythmic. The current highest-rated option is mexiletine hydrochloride. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 2 drugs we list for ventricular premature complexes, all are available as lower-cost generics, spanning classes such as antiarrhythmic. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for ventricular premature complexes — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Top-rated picks for ventricular premature complexes: 1. Mexiletine Hydrochloride · 2. Norpace

Top-rated treatments for ventricular premature complexes, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$8View →
264/100$25View →

Full ranking · 2 treatments

Frequently asked

What treats ventricular premature complexes?
Our catalog lists 2 products that may treat ventricular premature complexes, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is mexiletine hydrochloride.
What is the best-rated treatment for ventricular premature complexes?
By our independent recall-safety rating — not an efficacy measure — mexiletine hydrochloride ranks highest among the products we list for ventricular premature complexes. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat ventricular premature complexes?
Treatments for ventricular premature complexes span FDA drug classes including antiarrhythmic. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.